Direct-to-Consumer Genetic Testing: Market Research Report

July 2012 | 238 pages | ID: DDBAA080329EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Direct-to-Consumer Genetic Testing in US$ Million.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2018.

The report profiles 39 companies including many key and niche players such as 23andMe, Inc., Atlas Sports Genetics, LLC, deCODE genetics, DNA Direct, Inc., DNA Plus, Eastern Biotech & Life Sciences, Genelex Corporation, GeneLink Biosciences, Inc., Interleukin Genetics, Inc., Lumigenix Pty Ltd., MediChecks.com Ltd., Navigenics, Inc., and SeqWright, Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Direct-to-Consumer Genetic Testing – A Prelude
Current and Future Analysis
Growth Driving Factors
Ageing Population
Decreasing Costs
Privacy and Anonymity
Market Dynamics
Genetic Testing: Heralding a New Era
Creating A Platform for Genetic Testing Companies
Business Models for DTC Genetic Testing Firms
Waxing Prominence of DTC GT: A Boon or a Curse?
Challenges to Reckon with…
Better Regulatory Safeguards Required for Global DTC Genetic Testing Industry

2.DIRECT-TO-CONSUMER GENETIC TESTING: AN OVERVIEW

DTC Genetic Testing: An Introduction
Process of DTC Genetic Testing
Preface to Genetic Testing
Genetic Testing and its Applications
Select DTC Genetic Testing Companies and Tests Offered
Types of DTC Genetic Tests
Advantages of DTC Genetic Testing
Risks Involved in DTC Genetic Testing
Interpretation of Results
Positive-Tested Result
Negative-Tested Result

3.RECENT INDUSTRY ACTIVITY

Capsalus to Acquire Marketing Rights and Assets of GeneWize Life Sciences
OraSure Technologies Acquires DNA Genotek
easyDNA Inks Joint Venture Agreement with Philippines-based Harris DNA Testing Center
Sequenom Enters into European Licensing Agreement with LifeCodexx
Laboratory Corporation of America Holdings Acquires Orchid Cellmark
Medco Health Solutions Acquires DNA Direct
Bar Harbor BioTechnology Establishes New Division
Laboratory Corporation of America Holdings to Take Over Genzyme Genetic Counseling
Signal Genetics Enters into Partnership with Array BioPharma
Interleukin Genetics Inks Partnership Agreement with Amway Global
Navigenics Takes Over Affymetrix Clinical Services Laboratory
Pathway Genomics™ Enters into Partnership with OptumHealth Allies
Knome Collaborates with SeqWright
Progenika and ARUP Laboratories Enter into Agreement
Sequenom Acquires SensiGen

4.PRODUCT LAUNCHES/TECHNOLOGY DEVELOPMENTS

Interleukin Genetics Launches Better Online Weight Loss Services
DNA Direct Launches Novel Health Plan Clients to Manage Molecular Diagnostic and Genetic Tests
Knome Launches kGAP™ 2.0
Akonni Biosystems Launches TruTip Kit
Lineagen Launches FirstStepDx
InoLife Technologies Rolls Out DNA Predisposition Testing Product
LabCorp Launches Novel Paternity Test Using Promega Kits
GeneWize Life Sciences Introduces New LifeMap Me™ DNA Customized Skin Serum
CyGene Laboratories Launches DTC Predictive Genetic Products
Pathway Genomics Introduces Public DNA Testing Service
Illumina to Introduce Personal Genome Service

5.FOCUS ON SELECT GLOBAL PLAYERS

23ANDME, INC. (US)

Atlas Sports Genetics, LLC (US)
deCODE genetics (Iceland)
DNA Direct, Inc. (US)
DNA Plus (US)
Eastern Biotech & Life Sciences (Dubai)
Genelex Corporation (US)
GeneLink Biosciences, Inc. (US)
Interleukin Genetics, Inc. (US)
Lumigenix Pty Ltd. (Australia)
MediChecks.com Ltd. (UK)
Navigenics, Inc. (US)
SeqWright, Inc. (US)

6.GLOBAL MARKET PERSPECTIVE

Table 1. World Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing by Geographic Region/Country – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

Table 2. World 10-Year Perspective for Direct-to- Consumer Genetic Testing by Geographic Region/ Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2009, 2012 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis
Current and Future Analysis
Overview of DTC Genetic Testing Market in the US
Absence of Rigid Regulations, DTC Genetic Testing Faces Uncertainty
GAO Issues Report on Ambiguity in Results of DTC Genetic Testing
EGAPP Launched to Assess Effectiveness of Specific Genetic Tests
NIH Launches Public Database
AMA Demands Strict Regulation for DTC Genetic Testing
FDA to Closely Monitor DTC Genetic Testing Companies
FDA Increased Scrutiny over Announcement of Retail Availability of Pathway Genomics’ DTC Genetic Test
GINA to Safeguard Americans from Genetic Discrimination
ASHG Issues Guidelines on Ancestral DTC Genetic Testing
Product Launches
Recent Industry Activity
Key Players
B. Market Analytics

Table 3. US Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis
Current and Future Analysis
Regulatory Scenario in Canada
Recent Industry Activity
B. Market Analytics

Table 4. Canadian Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis
DTC Genetic Testing Market in Japan
Regulatory Scenario: Outline
B. Market Analytics

Table 5. Japanese Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis
Current and Future Analysis
Analysis by Country
Regulatory Environment in the EU: A Quick Primer
ESHG Advocates Regulation of Predictive DTC Gene Testing
B. Market Analytics

Table 6. European Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing by Geographic Region/Country – France, Italy, the UK, and Rest of Europe Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

Table 7. European 10-Year Perspective for Direct-to-Consumer Genetic Testing by Geographic Region/ Country – Percentage Breakdown of Dollar Sales for France, Italy, the UK, and Rest of Europe for Years 2009, 2012 and 2018 (includes corresponding Graph/Chart)

4A.FRANCE

A. Market Analysis
Current and Future Analysis
Regulatory Environment in France
B. Market Analytics

Table 8. French Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4B.ITALY

Market Analysis

Table 9. Italian Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4C.THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
Regulatory Scenario in the UK
Non-consensual Analysis of DNA Made Illegal
Principles for DTC Genetic Testing Laid out by HGC
MediChecks.com Ltd. – A Key Player from the UK
B. Market Analytics

Table 10. UK Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4D.REST OF EUROPE

A. Market Analysis
Current and Future Analysis
Product Launch
Key Player
B. Market Analytics

Table 11. Rest of Europe Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

5.REST OF WORLD

A. Market Analysis
Current and Future Analysis
Recent Industry Activity
Focus on Select Players
B. Market Analytics

Table 12. Rest of World Recent Past, Current and Future Analysis for Direct-to-Consumer Genetic Testing Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 39 (including Divisions/Subsidiaries - 44)
The United States (35)
canada (1)
Europe (5)
The United Kingdom (3)
Rest of Europe (2)
Asia-Pacific (Excluding Japan) (2)
Middle-East (1)